Back to search results

SynKIR-310 for Relapsed/Refractory B-NHL

Abroad (travel likely)RecruitingPHASE1

Conditions

B Cell Lymphoma · NHL, Adult · Mantle Cell Lymphoma · Relapsed Non-Hodgkin Lymphoma · Refractory Non-Hodgkin Lymphoma · Aggressive B-Cell Non-Hodgkin Lymphoma · Indolent B-Cell Non-Hodgkin Lymphoma · Follicular Lymphoma · Marginal Zone Lymphoma · DLBCL - Diffuse Large B Cell Lymphoma · HGBL With MYC and BCL2 and/or BCL6 Rearrangements · High-grade B-cell Lymphoma · Diffuse Large B Cell Lymphoma · Large B-cell Lymphoma · T-Cell/Histiocyte Rich Lymphoma · Non-hodgkin Lymphoma,B Cell · Primary Mediastinal Large B-cell Lymphoma (PMBCL) · Epstein-Barr Virus Positive DLBCL, Nos · Follicular Lymphoma Grade 3B · DLBCL (Diffuse Large B-Cell Lymphoma) Associated With Chronic Inflammation · High Grade B-Cell Lymphoma, Not Otherwise Specified · Follicular Lymphoma Grade 3 · Marginal Zone Splenic Lymphoma · DLBCL · Waldenstrom Macroglobulinemia · Waldenstrom Macroglobulinaemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute, Denver, Colorado, United States

    Contact: Study coordinator (Cicelia Veloz) · cicelia.veloz@sarahcannon.com · 720-754-8068
    Contact: Study coordinator (Autumn Wagner) · autumn.wagner@scri.com · 720-754-8068
    Contact: Principal Investigator (Michael T. Tees, MD)

  • Winship Cancer Institute of Emory University, Atlanta, Georgia, United States

    Contact: Study coordinator (Molly Stoddart) · molly.stoddart@emoryhealthcare.org · 404-778-6547
    Contact: Principal Investigator (Edmund Waller, MD, PhD)

  • The University of Kansas Cancer Center, Fairway, Kansas, United States

    Contact: Study coordinator (Nurse Navigator) · CTNurseNav@kumc.edu · 913-945-7552
    Contact: Principal Investigator (Joseph McGuirk, DO)

  • Rutgers Cancer Institute, New Brunswick, New Jersey, United States

    Contact: Study coordinator (Hem/Onc Clinical Trial Lab Manager) · tn293@cinj.rutgers.edu · 732-235-7315
    Contact: Principal Investigator (Matthew Matasar, MD)

  • Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Brittany Koch) · brittany.koch@pennmedicine.upenn.edu · 215-776-5548
    Contact: Principal Investigator (Stephen Schuster, MD)
Study leads

  • Laura A Johnson, PhD

    Study Chair

    Verismo Therapeutics

View source on ClinicalTrials.gov(opens in a new tab)